Engineered platelets deliver immunotherapy
نویسندگان
چکیده
منابع مشابه
Platelets deliver small packages of genetic function.
In this issue of Blood, Laffont et al have identified a type of delivery system by platelets in the form of platelet microparticles delivering functional microRNA to endothelial cells. The delivery, it appears, may be a relatively novel process of regulation of gene expression in endothelial cells and potentially other nucleated cells of the body.
متن کاملGenetically Engineered Multivalent Proteins for Targeted Immunotherapy.
mAbs initiated the unprecedented breakthroughs in cancer immunotherapy and are rapidly evolving with multiple therapeutic platforms. One next-generation strategy engineers multivalent proteins that ligate single-chain variable fragments targeting cellular effectors, tumor-associated antigens, and cytokines. These developing therapeutics target and regulate cellular effector bioactivity and sign...
متن کاملAn engineered IgA antibody for cancer immunotherapy
Division of Stem Cell Transplantation and Immunotherapy, 2 Department of Medicine, Christian-Albrechts-University, Schittenhelmstraße 12, 24105 Kiel, Germany Laboratory for Translational Immunology, Immunotherapy, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands Department of Biomolecular Systems, Max Planck Institute for Colloids and Interfaces, Am Mühlen...
متن کاملAdvancing Chimeric Antigen Receptor-Engineered T-Cell Immunotherapy Using Genome Editing Technologies: Challenges and Future Prospects
Chimeric antigen receptor engineered-T (CAR-T) cells also named as living drugs, have been recently known as a breakthrough technology and were applied as an adoptive immunotherapy against different types of cancer. They also attracted widespread interest because of the success of B-cell malignancy therapy achieved by anti-CD19 CAR-T cells. Current genetic toolbox enabled the synthesis of CARs ...
متن کاملMutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
Advances in nucleic acid sequencing technologies have revolutionized the field of genomics, allowing the efficient targeting of mutated neoantigens for personalized cancer vaccination. Due to their absence during negative selection of T cells and their lack of expression in healthy tissue, tumor mutations are considered as optimal targets for cancer immunotherapy. Preclinical and early clinical...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Drug Discovery
سال: 2017
ISSN: 1474-1776,1474-1784
DOI: 10.1038/nrd.2017.39